TW200640921A - Crystalline form of an indazole-carboxamide compound - Google Patents

Crystalline form of an indazole-carboxamide compound

Info

Publication number
TW200640921A
TW200640921A TW095105173A TW95105173A TW200640921A TW 200640921 A TW200640921 A TW 200640921A TW 095105173 A TW095105173 A TW 095105173A TW 95105173 A TW95105173 A TW 95105173A TW 200640921 A TW200640921 A TW 200640921A
Authority
TW
Taiwan
Prior art keywords
indazole
salts
crystalline form
carboxamide compound
crystalline
Prior art date
Application number
TW095105173A
Other languages
English (en)
Inventor
Paul R Fatheree
S D Turner
Robert S Chao
Jyan-Wei Liu
Hao Zhang
Junning Lee
Daniel Genov
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of TW200640921A publication Critical patent/TW200640921A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
TW095105173A 2005-02-17 2006-02-16 Crystalline form of an indazole-carboxamide compound TW200640921A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65367705P 2005-02-17 2005-02-17

Publications (1)

Publication Number Publication Date
TW200640921A true TW200640921A (en) 2006-12-01

Family

ID=36424659

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095105173A TW200640921A (en) 2005-02-17 2006-02-16 Crystalline form of an indazole-carboxamide compound

Country Status (5)

Country Link
US (1) US20060183901A1 (zh)
EP (1) EP1848716A1 (zh)
JP (1) JP2008530225A (zh)
TW (1) TW200640921A (zh)
WO (1) WO2006088988A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI377206B (en) * 2005-04-06 2012-11-21 Theravance Inc Crystalline form of a quinolinone-carboxamide compound
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
US7671198B2 (en) * 2006-02-16 2010-03-02 Theravance, Inc. Process for preparing intermediates to 5-HT4 receptor agonist compounds
WO2010022052A1 (en) * 2008-08-19 2010-02-25 Scinopharm Taiwan, Ltd. Polymorphic form of granisetron hydrochloride and methods of making the same
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AR080055A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de los receptores de crf -1
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937247A (en) * 1985-04-27 1990-06-26 Beecham Group P.L.C. 1-acyl indazoles
IT1226389B (it) * 1988-07-12 1991-01-15 Angeli Inst Spa Nuovi derivati ammidinici e guanidinici
JP3829879B2 (ja) * 1994-05-18 2006-10-04 大正製薬株式会社 キノリンカルボン酸誘導体
US5654320A (en) * 1995-03-16 1997-08-05 Eli Lilly And Company Indazolecarboxamides
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
US6069152A (en) * 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
ATE469897T1 (de) * 2004-12-22 2010-06-15 Theravance Inc Indazolcarbonsäureamidverbindungen

Also Published As

Publication number Publication date
JP2008530225A (ja) 2008-08-07
EP1848716A1 (en) 2007-10-31
WO2006088988A1 (en) 2006-08-24
US20060183901A1 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
TW200643020A (en) Crystalline form of a quinolinone-carboxamide compound
TW200640921A (en) Crystalline form of an indazole-carboxamide compound
MY139296A (en) CRYSTALLINE ß2 ADRENERGIC RECEPTOR AGONIST
MXPA05012678A (es) Forma cristalina del agonista del receptor adrenergico beta2.
MA29088B1 (fr) Composes d&#39;indazole-carboxamide.
AP1822A (en) Substituted pyridinones as modulators of P38 MAP kinase.
MY155036A (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
IL184898A0 (en) Pyrrolopyrimidine derivatives and pharmaceutical compositions containing the same
TW200800981A (en) 8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists
HK1096673A1 (en) Compositions useful as inhibitors of protein kinases
WO2006052889A3 (en) Quinolinone-carboxamide compounds
PL1957484T3 (pl) Antagoniści receptora glukagonu, wytwarzanie i zastosowanie w lecznictwie
EA200970500A1 (ru) СОЕДИНЕНИЯ ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛА В КАЧЕСТВЕ МОДУЛЯТОРОВ РЕЦЕПТОРА АНДРОГЕНОВ
TW200716607A (en) Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
TW200606164A (en) New compounds
TN2012000132A1 (en) N-((1r,2s,5r)-5-(tert-butylamino)-2-((s)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
SI1853232T1 (sl) Stabilna kristalna oblika bifeprunoks-mezilata, njegove dozirne oblike in postopki za njihovo uporabo
MX2009009141A (es) Formas cristalinas de un compuesto de 8-azabiciclo[3,2,1]octano.
TW200800984A (en) New compounds
BR0308592A (pt) Derivados de piperidina ou 8-azabiciclo [3.2.1] oct-3-il-piperidina, de utilidade como moduladores da atividade do receptor de quimocina (especialmente ccr5)
ATE450511T1 (de) Kristalline formen eines arylanilin-beta-2- adrenergenrezeptor-agonists
NO20090190L (no) Modulatorer av kjemokin reseptor aktivitet, krystallinske former og fremgangsmate
NO20080671L (no) Bisykliske piperaziner som metabotrofiske glutamatreseptorantagonister
MY179041A (en) Crystalline forms of a 3-carboxypropyl-aminotetralin compound
MY143574A (en) Carbamate compounds as 5-ht4 receptor agonists